For amino acid metabolism, the protein expression level of branched-chain amino acid transaminase 2 (BCAT2) is significantly increased in prostate cancer cells, which allows cancer cells to more efficiently use branched-chain amino acids (BCAAs) as energy sources and raw materials for biosynthesis, thereby promoting the rapid growth of cancer cells. Here, BCAT2 is linked to prostate carcinoma.